30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Noubar Afeyan

Track

Insider profile

Currently holds positions in Rubius Therapeutics Inc and Moderna Inc

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 13% 8.2% 15.1%
Success rate 99% 68% 82%
Transactions
13 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Rubius Therapeutics Inc Jan. 1, 2013 -
Non-Executive Independent Chairman of the Board, Co-Founder Moderna Inc Feb. 1, 2012 -
Lead Independent Director Seres Therapeutics Inc Jan. 1, 2016 - March 23, 2020
Chairman of the Board Evelo Biosciences Inc Jan. 1, 2017 - Sept. 17, 2019
Director Evelo Biosciences Inc None -
Director Seres Therapeutics Inc Oct. 1, 2010 - Jan. 1, 2016
Director Carisma Therapeutics Inc Feb. 1, 2008 - Nov. 12, 2014
Noubar Afeyan's trades of Moderna Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-22 2026-05-21
US Moderna Inc (MRNA)
S Sale
78,918 +6.7%
175.45
US$92,249 		78,918 +6.7% 175.45 US$92,249
2026-03-02 2026-03-02
B Purchase
98,127 -24.8%
468.75
US$2,957,639 		98,127 -24.8% 468.75 US$2,957,639
2026-03-02 2026-03-02
B Purchase
9,446 +27.3%
273.69
US$1,430,872 		9,446 +27.3% 273.69 US$1,430,872
2026-03-02 2026-03-02
B Purchase
1,562,500 +11.4%
16.00
US$25,000,000 		1,562,500 +11.4% 16.00 US$25,000,000
2026-03-02 2026-03-02
B Purchase
1,562,500 +inf%
16.00
US$25,000,000 		1,562,500 +inf% 16.00 US$25,000,000
2026-03-02 2026-03-02
B Purchase
1,562,500 +56.3%
16.00
US$25,000,000 		1,562,500 +56.3% 16.00 US$25,000,000
2026-03-02 2026-03-02
B Purchase
1,562,500 +11.4%
16.00
US$25,000,000 		1,562,500 +11.4% 16.00 US$25,000,000
2025-12-15 2025-12-11
US Moderna Inc (MRNA)
S Sale
23,853 -85.9%
29.49
US$703,306 		23,853 -85.9% 29.49 US$703,306
2024-08-02 2024-07-31
US Moderna Inc (MRNA)
PlS Planned sale
1,309 -0.1%
121.62
US$159,204 		1,309 -0.1% 121.62 US$159,204
2024-08-02 2024-07-31
US Moderna Inc (MRNA)
PlS Planned sale
3,428 -0.2%
120.88
US$414,377 		3,428 -0.2% 120.88 US$414,377
2024-08-02 2024-07-31
US Moderna Inc (MRNA)
PlS Planned sale
5,664 -0.3%
119.84
US$678,754 		5,664 -0.3% 119.84 US$678,754
2024-08-02 2024-07-31
US Moderna Inc (MRNA)
PlS Planned sale
4,599 -0.2%
118.96
US$547,107 		4,599 -0.2% 118.96 US$547,107
2024-07-31 2024-07-31
US Moderna Inc (MRNA)
PrS Proposed sale
15,000
118.84
US$1,782,600 		15,000 118.84 US$1,782,600
2024-07-26 2024-07-24
US Moderna Inc (MRNA)
PlS Planned sale
2,000 -0.1%
119.01
US$238,026 		2,000 -0.1% 119.01 US$238,026
2024-07-26 2024-07-24
US Moderna Inc (MRNA)
PlS Planned sale
6,832 -0.3%
118.30
US$808,208 		6,832 -0.3% 118.30 US$808,208
2024-07-26 2024-07-24
US Moderna Inc (MRNA)
PlS Planned sale
3,500 -0.2%
117.25
US$410,376 		3,500 -0.2% 117.25 US$410,376
2024-07-26 2024-07-24
US Moderna Inc (MRNA)
PlS Planned sale
2,668 -0.1%
116.33
US$310,362 		2,668 -0.1% 116.33 US$310,362
2024-07-24 2024-07-24
US Moderna Inc (MRNA)
PrS Proposed sale
15,000
121.25
US$1,818,750 		15,000 121.25 US$1,818,750
2024-07-19 2024-07-17
US Moderna Inc (MRNA)
PlS Planned sale
700 -0.0%
124.61
US$87,230 		700 -0.0% 124.61 US$87,230
2024-07-19 2024-07-17
US Moderna Inc (MRNA)
PlS Planned sale
6,699 -0.3%
123.82
US$829,478 		6,699 -0.3% 123.82 US$829,478
2024-07-19 2024-07-17
US Moderna Inc (MRNA)
PlS Planned sale
2,900 -0.1%
122.86
US$356,298 		2,900 -0.1% 122.86 US$356,298
2024-07-19 2024-07-17
US Moderna Inc (MRNA)
PlS Planned sale
2,100 -0.1%
121.57
US$255,297 		2,100 -0.1% 121.57 US$255,297
2024-07-19 2024-07-17
US Moderna Inc (MRNA)
PlS Planned sale
2,601 -0.1%
120.86
US$314,347 		2,601 -0.1% 120.86 US$314,347
2024-07-17 2024-07-17
US Moderna Inc (MRNA)
PrS Proposed sale
15,000
125.14
US$1,877,100 		15,000 125.14 US$1,877,100
2024-07-12 2024-07-10
US Moderna Inc (MRNA)
PlS Planned sale
500 -0.0%
119.95
US$59,976 		500 -0.0% 119.95 US$59,976
2024-07-12 2024-07-10
US Moderna Inc (MRNA)
PlS Planned sale
1,100 -0.0%
119.28
US$131,211 		1,100 -0.0% 119.28 US$131,211
2024-07-12 2024-07-10
US Moderna Inc (MRNA)
PlS Planned sale
3,000 -0.1%
117.83
US$353,483 		3,000 -0.1% 117.83 US$353,483
2024-07-12 2024-07-10
US Moderna Inc (MRNA)
PlS Planned sale
4,279 -0.2%
117.18
US$501,418 		4,279 -0.2% 117.18 US$501,418
2024-07-12 2024-07-10
US Moderna Inc (MRNA)
PlS Planned sale
6,121 -0.3%
116.01
US$710,089 		6,121 -0.3% 116.01 US$710,089
2024-07-10 2024-07-10
US Moderna Inc (MRNA)
PrS Proposed sale
15,000
116.07
US$1,741,050 		15,000 116.07 US$1,741,050
2024-06-28 2024-06-26
US Moderna Inc (MRNA)
PlS Planned sale
100 -0.0%
134.05
US$13,405 		100 -0.0% 134.05 US$13,405
2024-06-28 2024-06-26
US Moderna Inc (MRNA)
PlS Planned sale
700 -0.0%
131.56
US$92,089 		700 -0.0% 131.56 US$92,089
2024-06-28 2024-06-26
US Moderna Inc (MRNA)
PlS Planned sale
2,705 -0.1%
130.76
US$353,695 		2,705 -0.1% 130.76 US$353,695
2024-06-28 2024-06-26
US Moderna Inc (MRNA)
PlS Planned sale
2,300 -0.1%
129.84
US$298,631 		2,300 -0.1% 129.84 US$298,631
2024-06-28 2024-06-26
US Moderna Inc (MRNA)
PlS Planned sale
1,435 -0.1%
128.78
US$184,798 		1,435 -0.1% 128.78 US$184,798
2024-06-28 2024-06-26
US Moderna Inc (MRNA)
PlS Planned sale
1,100 -0.0%
127.50
US$140,254 		1,100 -0.0% 127.50 US$140,254
2024-06-28 2024-06-26
US Moderna Inc (MRNA)
PlS Planned sale
1,100 -0.0%
125.71
US$138,277 		1,100 -0.0% 125.71 US$138,277
2024-06-28 2024-06-26
US Moderna Inc (MRNA)
PlS Planned sale
1,500 -0.1%
124.90
US$187,352 		1,500 -0.1% 124.90 US$187,352
2024-06-28 2024-06-26
US Moderna Inc (MRNA)
PlS Planned sale
1,600 -0.1%
123.74
US$197,978 		1,600 -0.1% 123.74 US$197,978
2024-06-28 2024-06-26
US Moderna Inc (MRNA)
PlS Planned sale
2,460 -0.1%
122.69
US$301,814 		2,460 -0.1% 122.69 US$301,814
2024-06-26 2024-06-26
US Moderna Inc (MRNA)
PrS Proposed sale
15,000
137.60
US$2,064,000 		15,000 137.60 US$2,064,000
2024-06-21 2024-06-18
US Moderna Inc (MRNA)
PlS Planned sale
100 -0.0%
136.92
US$13,692 		100 -0.0% 136.92 US$13,692
2024-06-21 2024-06-18
US Moderna Inc (MRNA)
PlS Planned sale
200 -0.0%
135.02
US$27,003 		200 -0.0% 135.02 US$27,003
2024-06-21 2024-06-18
US Moderna Inc (MRNA)
PlS Planned sale
6,840 -0.3%
134.09
US$917,197 		6,840 -0.3% 134.09 US$917,197
2024-06-21 2024-06-18
US Moderna Inc (MRNA)
PlS Planned sale
6,160 -0.3%
133.26
US$820,887 		6,160 -0.3% 133.26 US$820,887